Invention Application
- Patent Title: MACROCYCLIC COMPOUND AND USES THEREOF
-
Application No.: US16500924Application Date: 2018-04-03
-
Publication No.: US20200148698A1Publication Date: 2020-05-14
- Inventor: Yoshito Kishi , Kazunobu Kira , Ken Ito
- Applicant: President and Fellows of Harvard College , Eisai R&D Management Co., LTD.
- Applicant Address: US MA Cambridge JP Tokyo
- Assignee: President and Fellows of Harvard College,Eisai R&D Management Co., LTD
- Current Assignee: President and Fellows of Harvard College,Eisai R&D Management Co., LTD
- Current Assignee Address: US MA Cambridge JP Tokyo
- International Application: PCT/US2018/025887 WO 20180403
- Main IPC: C07D493/22
- IPC: C07D493/22 ; A61K31/357 ; A61K39/395 ; A61P35/00 ; C07K16/28
Abstract:
The present invention provides novel Compound (1) having tumor vascular remodeling effect and/or anti-CAF (Cancer Associated Fibroblasts) activity, or a pharmaceutically acceptable salt thereof, optionally in a pharmaceutically acceptable and medical uses thereof.
Public/Granted literature
- US10954249B2 Macrocyclic compound and uses thereof Public/Granted day:2021-03-23
Information query
